Offer - Urjas Oil for just ₹ 1
Meftaris is a commercial drug that is prescribed in the form of Tablet. Meftaris also has some secondary and off-label uses. These are listed below.
The right dosage of Meftaris depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Meftaris as well, which are listed below. Usually, these side effects of Meftaris go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Meftaris's effect during pregnancy is Severe and Severe while nursing. Warnings related to Meftaris's effects on the liver, heart and kidney, if any, have been listed below.
Meftaris is not recommended if you suffer from certain medical conditions as it can have adverse effects. Blood Cancer, Colour Blindness, Allergy are examples of such conditions. The section on Meftaris contraindications lists all such conditions.
Additionally, Meftaris may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Meftaris is safe while driving, and is is addictive in nature.
Meftaris is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Meftaris safe for pregnant women?
Meftaris shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Meftaris safe during breastfeeding?
Taking Meftaris may lead to serious side effects if you are breastfeeding. Meftaris should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Meftaris on the Kidneys?
Meftaris has very mild side effects on the kidneys.
What is the effect of Meftaris on the Liver?
Meftaris is rarely harmful for the liver.
What is the effect of Meftaris on the Heart?
Side effects of Meftaris rarely affect the heart.
Meftaris should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Meftaris unless your doctor advises you to do so -
Is this Meftaris habit forming or addictive?
Meftaris is not addictive in nature.
Interaction between Food and Meftaris
You can take Meftaris with food.
Interaction between Alcohol and Meftaris
Taking alcohol with Meftaris can be dangerous.
Yes, it is safe to take Meftaris for as long as it is prescribed by your doctor. In some people, however, it may cause some side effects like chest pain, muscle, joint or bone pain. rash, and shortness of breath Please inform your doctor if you suffer from any of these side effects.
Meftaris stops the process of fibrinolysis during which the blood clots are broken, resulting in excessive bleeding. In this way, Meftaris reduces the blood loss from the body.
No, Meftaris doesn't delay periods. It is given during periods to reduce the excessive loss of blood in women with heavy bleeding.
No, Meftaris is not an NSAID (non-steroidal anti-inflammatory drug). It is an anti-fibrinolytic agent that stops the process of fibrinolysis, preventing blood loss.
No, Meftaris doesn't prolong periods. It may or may not shorten the duration of the period because it mainly reduces the blood loss during periods.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 628-629
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lysteda™ (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyklokapron® (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ponstel® (Mefenamic Acid)
